免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

Genomadix Cube CYP2C19 System

K号: K220026 · 2023-03-21

决定日期2023-03-21
产品代码NTI
咨询委员会TX 请注意,由于您没有提供具体的医疗设备监管文本,我无法进行翻译。请提供具体的文本内容,以便我能够按照您的要求进行翻译。
决定实质等同

器械摘要

Genomadix Cube CYP2C19 System is the device name listed in this FDA 510(k) record. The listed applicant is Genomadix, Inc.. It received FDA 510(k) clearance on 2023-03-21 under 510(k) number K220026. The device is classified under product code NTI. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Genomadix Cube CYP2C19 System?

Genomadix Cube CYP2C19 System is a medical device that received FDA 510(k) clearance on 2023-03-21. The listed applicant is Genomadix, Inc.. The 510(k) number is K220026.

When did Genomadix Cube CYP2C19 System receive FDA 510(k) clearance?

Genomadix Cube CYP2C19 System received FDA 510(k) clearance on 2023-03-21, under 510(k) number K220026.

Who is the listed applicant for Genomadix Cube CYP2C19 System?

The FDA 510(k) record lists Genomadix, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Genomadix Cube CYP2C19 System?

The FDA product code for Genomadix Cube CYP2C19 System is NTI.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:NTI)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑